The World Trade Hub

Active Pharmaceutical Ingredient (API) & Pharmaceutical Drug Supply

WHAT WE DO

The Indian pharmaceuticals market is the third largest in terms of volume with 20-22% of total generic medicines exports being supplied from India. India and has established itself as a global manufacturing and a research hub and boasts of having one of the lowest manufacturing costs in the world.

The World Trade Hub has partered with top pharmaceutical companies and has the ability to source almost any generic pharma drug produced. We also customize orders based on individual client and country requirements.

Trade APIs (Active Pharmaceutical Ingredients) and Pharmaceutical Drugs

The World Trade Hub works with trusted API (Active Pharmaceutical Ingredient) and pharmaceutical drug manufacturers and suppliers. We facilitate the sourcing of APIs and pharmaceutical drugs as per customer requirements from pre-screened pharma companies that have demonstarted capabilities and have a proven track record.

Facilitate Partnerships

The World Trade Hub facilitates the exports of APIs and pharmaceutical drugs by matching pre-screened manufacturers that have demonstrated their capabilities. We are dedicated to building long-term partnerships between global clients by identifying the most cost-efficient and innovative solutions partner for our customers.

Research & Development of Drugs

India is a key player in drug development studies and trials. The World Trade Hub has partnered with JCDC, a leading research organization in India to provide end-to-end support in terms of administration and infrastructure to meet global standards. We also have partnered with manufacturing facilities that are equipped to manufacture custom drugs.

We take advantage of India's advances in R&D and low-cost production model and pass on these benefits to clients to make healthcare more universal and affordable.

Our partners adhere to the cGMP (Current Good Manufacturing Practices), FDA-approved guide- lines and are registered with the CDSCO (Central Drugs Standard Control Organization).

The Indian government's support and recent initiative, ‘Pharma Vision 2020’ aims to put India as a top global drug manufacturer. We leverage these initiatives to provide world-class solutions to our global clients.

The World Trade Hub Advantage

The World Trade Hub serves as the single point of contact in the context of any inquiries, updates, business or research ideas, and also escalations encompassing all the operations within the jurisdiction of our global hub. We also facilitate seamless trade by helping our customers navigate through the maze of local, national, and international regulations and policies and effectively boost international trade.

We ensure that the drug manufacturing, supply, and research studies adhere to the internationally accepted standards of cGMP (Current Good Manufacturing Practices), CDSCO (Central Drugs Standard Control Organization), USFDA (United States Food and Drug Administration), and WTO (World Trade Organization).

The World Trade Hub works towards expediting the flow of API and pharmaceutical drugs’ trade by thoroughly validating, cross-checking and ensuring the alignment of the specific customer requirements with our proposed solutions partner from the outset of the trade thereby preventing any performance gaps.

The World Trade Hub strives to create and sustain an affordable end-to-end model of drug innovation, production, and supply to the global medical industry.

Looking to source affordable and world-class pharmaceutical drugs and API?
Look no further. The World Trade Hub is the place to be.